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Abstract
The accurate assessment of antimicrobial use (AMU) requires relating quantities of active ingredients (AAIs) with
population denominators. These data can be used to prioritize potential sources of selective pressure for
antimicrobial resistance and to establish reduction targets. Here, we estimated AMU in Vietnam (human population
93.4 M in 2015), and compared it with European Union (EU) data (population 511.5 M in 2014). We extrapolated
AMU data on each key animal species and humans from different published sources to calculate overall AMU (in
tonnes) in Vietnam. We then compared these data with published statistics on AMU in the European Union (EU). A
total of 3838 t of antimicrobials were used in Vietnam, of which 2751 (71.7%) corresponded to animal use, and the
remainder (1086 t; 28.3%) to human AMU. This equates to 261.7 mg and 247.3 mg per kg of human and animal
biomass, compared with 122.0 mg and 151.5 mg in the EU. The greatest quantities of antimicrobials (in decreasing
order) were used in pigs (41.7% of total use), humans (28.3%), aquaculture (21.9%) and chickens (4.8%). Combined
AMU in other species accounted for < 1.5%. These results are approximate and highlight the need to conduct
targeted surveys to improve country-level estimates of AMU.
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Main text
Antimicrobial resistance (AMR) in bacterial pathogens is
now firmly recognized as major global health problem
[1]. AMR arises as a direct consequence of antimicrobial
usage (AMU) in humans and animals and resistant or-
ganisms and AMR-encoding genes are capable of cross-
ing species barriers [2]. Therefore, the emergence and
transfer of AMR means that control solutions need to be
conducted from a ‘One Health’ perspective [3]. However,
if we are to reduce AMR we need accurate estimates of
where the majority of AMU occurs. Sustained surveil-
lance and monitoring of AMU are widely acknowledged
as critical components of the fight against AMR and one
of the strategic priorities of the AMR Global Action Plan
(GAP) [4].
There is considerable uncertainty regarding AMU in
different animal species and humans in most countries.
This knowledge gap is due to the absence of reliable
AMU data in humans and animals and ill-defined animal
population denominators. Many higher income coun-
tries, such as those within the European Union (EU),
regularly publish their data on AMU in humans and ani-
mals, and relate these values to denominator populations
in terms of biomass [5]. Conversely, the majority of low-
and middle-income countries (LMICs) do not regularly
collect and report equivalent AMU statistics.
Recently, the World Organization for Animal Health
(OIE) estimated that worldwide, on average 168.7 mg of
antimicrobial active ingredients (AAIs) were used to
raise 1 kg of animal biomass [6]. Although the report
does not include between-country- or species-specific
data, it shows however considerable differences between
different OIE regions. However, this report did not indi-
cate which animal production sectors are responsible for
the largest degree of AMU. Such data are essential for
estimating where AMR is most likely to be generated
and maintained and pivotal for policy makers to set re-
duction targets. Here, by integrating various data
sources, we aimed to estimate AMU in humans and dif-
ferent animal populations in Vietnam. These data were
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compared against available human and animal AMU sta-
tistics from the EU.
Human biomass in Vietnam was calculated using 2015
population data stratified by age [7]. Adult (> 18 years-
old) body weight was taken from published Figs. (58.4 kg
males; 50.8 kg females) [8]. For non-adult age-gender
strata, we assigned bodyweights to US populations [9],
after adjusting for the difference in body mass between
populations in the two countries. This was achieved by
applying the correction factors of 0.642 and 0.651, which
represent, respectively, the ratios of weights of adult
males and adult females in the two countries. The total
biomass of terrestrial animals in Vietnam was calculated
from official statistics [10] following the approach used
by the OIE [6] that combined data on the number of
slaughtered animals and standing populations. For aqua-
culture (farmed fish and shellfish), production data
broken down by type of market (domestic, export)
(2016) were used [11].
Data on human AMU in Vietnam were extracted from
a multi-country survey in hospitals and the community
[12]. The reported number of Defined Daily Doses
(DDD) (per 1000) were converted to weight of anti-
microbial active ingredient (AAI) using the four most
common administered antimicrobials (ceftriaxone, ampi-
cillin, azithromycin and levofloxacin). The daily con-
sumption data was extrapolated for a whole year (365
days).
For pigs, chickens, and aquaculture (all aquatic species
combined) data on AMU were obtained from quantita-
tive published surveys [13–16]. Data on on AMU
through consumption of commercial feed (i.e. antimicro-
bial growth promoters) were extrapolated from a survey
of 1462 pig and chicken commercial feeds in Vietnam
[17]. Antimicrobial consumption in aquaculture was ex-
trapolated from a previous study [18], assuming that, on
average, antimicrobial products have a 20% strength
(weight of AAI related to total weight of product) based
on the same study. For ruminants (bovines, buffaloes,
sheep, goats) data on AMU in Japan (a high-income
country in Asia) for 2010 were used [19]. For non-
chicken poultry species (ducks, Muscovy ducks, geese
and quails) the authors could not find any published
data. AMU was, therefore, conservatively estimated as
50% of that reported in chickens, based on the authors’
field experience. We excluded companion animals and
equines since no AMU data are available. Best and
worst-case AMU scenarios (i.e. lowest and highest
AMU) were calculated for all species: for poultry species,
upper and lower limits were calculated based on ±25%
of the final AMU estimate. For ruminants, the lower
limit of AMU was taken from Japanese cattle AMU sta-
tistics [19]. The upper limit was set at 50% higher than
this estimate; for our summary estimations we used the
intermediate value between these two limits. We com-
pared the resulting AMU data with those published in
the second ECDC/EFSA/EMA Joint Report on AMU
(data for 2014), corresponding with AMU data in rela-
tion to the total biomass of terrestrial animal species in
28 EU countries [5] as well as with the Third World
Organization for Animal Health (OIE) Report [6] (data
for 2015).
Our estimates of human and animal biomass in
Vietnam from the above calculations are 4153 and 11,
125 thousand tonnes, respectively (Table 2 in Appendix
1 and Table 1). Estimates of AMU showed that in 2015,
a total of 3842 t of antimicrobials were used in Vietnam,
of which 2751 (71.7%) was associated with animal use,
and the remainder (1086 t; 28.3%) corresponded to hu-
man AMU. The greatest quantities of antimicrobials (in
decreasing order) were used in pigs (41.7% of total use),
humans (28.3%), aquaculture (21.9%) and chickens
(4.8%). Combined AMU in other species accounted for
< 1.5% (Table 1 and Fig. 1). We estimate that, in total,
261.7 mg (131.4–394.3 mg) of AAI were administered
per 1 kg of human and 247.3 mg (130.3–364.3 mg) per 1
kg of animal in Vietnam. The corresponding figures
from the EU were 122.0 mg/kg and 151.1 mg/kg in
humans and animals, respectively (Fig. 2).
Here, using a combination of available statistics along-
side published AMU survey and extrapolation data, we
estimated AMU related to biomass in humans and ani-
mal production in Vietnam. Our results suggest that in
this country pig production and aquaculture should be
the main target if the country aims to reduce its AMU
footprint in animal production. AMU in humans in
Vietnam (32.0 DDD per 1000 inhabitants per day) ranks
higher than in most countries in the EU. These human
data were generated using limited retail surveys [12].
However, EU countries such as Romania, Greece,
France, Spain, and Ireland featured a higher magni-
tude of AMU (in terms of DDD related to popula-
tion) than Vietnam. A recent report from Thailand,
a LMIC country which is more comparable to
Vietnam, estimated that in 2017 a total of 53.0 DDD
per 1000 inhabitants per day were used in 2017 [20].
The Thai study used surveillance data on declared
quantities of antimicrobials, which is a compulsory
requirement for companies trading with antimicro-
bials in that country.
Whilst these are the first specific calculations for
AMU in Vietnam, there is a considerable uncertainty
around these estimates due to the lack of reliable
data. For example, AMU data in humans, pigs, and
aquaculture originate from single studies, all con-
ducted prior to 2015. Furthermore, there are no data
whatsoever on AMU in non-chicken poultry species
and ruminants. The situation is likely to be even
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worse in other LMICs where there are practically no
AMU data in any production sector.
Since different animal types are raised over vari-
able periods, the same magnitude of AMU related to
body mass may have different implications for the
development and maintenance of AMR For example,
in Vietnam chickens are raised over a period ranging
from 1 to 5 months, compared with 5–8 months for
pigs. The implications of this need to be further
investigated.
Because of its relative simplicity, we propose to regu-
larly (i.e. annually) estimate/update quantities of antimi-
crobials used in relation to body mass as a first step to
develop a fully-fledged AMU surveillance system. These
estimates could be fine-tuned by conducting targeted
surveys tailored to different production types (i.e. meat
chickens, layers, breeders, fattening pigs, etc.). It may
also be necessary to differentiate the extent of AMU by
level of intensification of the production system (i.e.
backyard, small-scale, large-scale, industrial), as different
systems require variable quantities of antimicrobials. It
has been shown that in the Mekong Delta of Vietnam
smaller chicken farms tend to use more antimicrobials
[13]. Lastly, it would be desirable to incorporate detailed
information regarding the classes and formulations of
antimicrobials used, since there is a great variability
Table 1 Calculation of total annual AMU in each animal production type
Category Sub-category No. of
animals
Type of
dataa
Weight
unit (kg)
Annual
bodymass
(kg)
AMUb (mg
per kg)
AGPs in commercial
feed (mg per kg)
Total
AMU (mg
per kg)
Total AMU
(tonnes)
Swine Breeding pigs 4,128,
032
Census 240 990,727,726 46.11 286.62 332.7 329.6
Slaughter pigs (except
breeders)
48,567,
582
Production 78.6 3,817,411,
914
46.11 286.62 332.7 1270.1
Poultry Chickens 88,777,
000
Production 1.8 699,798,600 187.73, 4 77.42 265.1 185.5
Ducks 101,931,
884
Production 2 203,863,767 93.95 38.75 132.6 27.0
Muscovies 17,652,
638
Production 3.2 56,488,440 93.95 38.75 132.6 7.5
Geese 641,212 Production 3.2 2,051,877 93.95 38.75 132.6 0.3
Quails 13,526,
147
Production 0.13 1,758,399 93.95 38.75 132.6 0.2
Bovine Breeding bovines 3,472,
891
Census 325 1,128,330,
008
52.46 0.0 52.4 59.1
Slaughter bovines
(except breeding
animals)
1,220,
131
Production 200 244,026,240 52.46 0.0 52.4 12.8
Buffalo Breeding buffaloes 378,549 Population 500 189,274,500 52.46 0.0 52.4 9.9
Slaughter buffaloes 297,216 Production 300 89,164,711 52.46 0.0 52.4 4.7
Sheep Breeding animals (est.) 26,901 Census 75 2,017,556 52.46 0.0 52.4 0.1
Number slaughtered
(except breeders)
64,368 Production 75 4,827,600 52.46 0.0 52.4 0.3
Goats Breeding animals (est.) 444,411 Census 75 33,330,833 52.46 0.0 52.4 1.7
Number slaughtered
(except breeders)
699,515 Production 75 52,463,597 52.46 0.0 52.4 2.7
Aquaculture All species (domestic) – Production 835,000,000 477.17 – 477.17 398.5
All species (export) – Production 2,775,000,
000
159.18 – 159.18 441.4
All animals 11,125,535,
768
2751.4
AMU Antimicrobial use, AGPs Antimicrobial growth promoters (in commercial feed)
aData derived from official country statistics [10, 11]. ‘Census’ refers to ‘No. standing animals’, ‘Production’ refers to ‘No. of slaughtered animals’, except for
aquaculture, where it refers to ‘No. of kg produced’
bExcluding antimicrobial growth promoters in commercial feed; 1 Nguyen et al. (2016) [15]; 2 Van Cuong et al. (2016) [17]; 3,4 Average of two studies: Carrique-Mas
et al. (2014) [13] and Cuong et al. (2019) [14]; 5 Based on 50% of quantities used in chicken production; 6 Hosoi et al. (2014) [19]; 7 Pham et al. (2015) [16]; 8
Assuming that AMU for export production is 1/3 of the magnitude of AMU for domestic production
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regarding the strength of different antimicrobial prod-
ucts and their impact on development of AMR.
In conclusion, in the absence of reliable statistics on
sales of AAIs, the challenges of monitoring AMU in ani-
mal production in LMICs such as Vietnam can be
overcome by the use of innovative approaches that
maximize the use of existing animal population statistics
and AMU data. These estimates should help elucidate
secular changes in AMU and help refine policies and in-
terventions aimed at reducing AMU at country level.
Fig. 1 Two-dimensional diagram representing the estimated annual amounts (areas of bars) of antimicrobials used in each of species (including
humans) in Vietnam, and whether these quantities are more affected by the total biomass (width of bars) or the intensity of AMU (height of
bars). Bars are sorted from higher to lower overall AMU. AMU = Antimicrobial use. The vertical lines represent the range between best- and worst-
case scenarios. ‘Other avian’ includes ducks, muscovies, geese and quails
Fig. 2 Two-dimensional diagram showing the relative annual amounts of AMU in the European Union (2014) and in Vietnam. In order to render
comparison between European Union and Vietnam possible, the biomasses of animals and humans on the x-axis have been scaled to
proportions. AMU = Antimicrobial use
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